Raltegravir (MK-0518)
 
       商品编号:
        
         TS0461
         
        
        
       
       
       
      
         
          
备注:
 如需更大包装,请联系销售人员,大包装有极大的折扣优惠!
          
       
       
       
       
        
        
详细介绍
 
       
              
          l  基本信息  | 
产品名称  | 雷特格韦(Raltegravir (MK-0518))  | 
一般描述  | Raltegravir is a Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor.  | 
别 称  | N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide  | 
纯 度  | ≥98.0%(HPLC)  | CAS NO.  | 518048-05-0  | 
分子式  | C20H21FN6O5  | 分子量  | 444.42  | 
适用范围  | 生物试剂,适用于细胞培养等  | 
l  理化信息  | 
外 观  | 固体  | 
溶解性(25℃)  | DMSO  | ≥50mg/mL  | 
乙醇  | Insoluble  | 
水  | Insoluble  | 
l  生物学信息  | 
生物活性/药理作用  | Raltegravir is a small molecule with activity against human immunodeficiency virus (HIV). Raltegravir is an integrase inhibitor that blocks the integration of the viral genome into the host DNA, a critical step in the pathogenesis of HIV. Raltegravir (MK-0518) is a potent integrase (IN) inhibitor for WT and S217Q PFV IN with IC50 of 90 nM and 40 nM in cell-free assays, respectively. It shows greater than 1000-fold selectivity for HIV-1 IN over several related Mg2+-dependent enzyme such as HCV polymerase, HIV reverse tranase, HIV RNaseH and human α-, β-, γ-polymerases.  | 
l  存储  | 
存储温度  | -20℃  | 
l  注意事项及免责声明  | 
本产品仅用于实验研究,不得作为药物使用,不得用于家用或其它用途。  | 
l  参考文献  | 
1.    http://www.drugbank.ca 2.    https://ncit.nci.nih.gov 3.    https://www.ncbi.nlm.nih.gov  |